Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025
Go back to Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025| (NASDAQ: LPTX) | Delayed: 2.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.06 | 52 Week High | $ | |||
| Open | $2.06 | 52 Week Low | $ | |||
| Day High | $2.06 | P/E | N/A | |||
| Day Low | $2.06 | EPS | $ | |||
| Volume | 27,009 | |||||

